StockData
Kodiak Sciences Inc. logo

Kodiak Sciences Inc. (KOD) stock

KODNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$97.17−0.73 (-0.75%)

Close on Nov 20, 2026Market cap $6.11BP/E –Yield –

Kodiak Sciences gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for Kodiak Sciences

Kodiak Sciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Kodiak Sciences figures

See a number that looks wrong?